News/ News/ R&D Lynparza on cusp of approval for advanced ovarian cancer Joy Persaud Lynparza, olaparib, ovarian cancer 0 Comment Breast cancer drug Lynparza (olaparib) is poised for EU approval for the first-line treatment of a certain type Share X Lynparza on cusp of approval for advanced ovarian cancer https://pharmaphorum.com/news/lynparza-on-cusp-of-approval-for-advanced-ovarian-cancer/
